EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 41 / No 2 (Février 2025) Med Sci (Paris), 41 2 (2025) 173-179 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 2, Février 2025
Page(s) 173 - 179
Section Repères
DOI https://doi.org/10.1051/medsci/2025016
Published online 03 March 2025
  1. Luft R. The development of mitochondrial medicine. Proc Natl Acad Sci USA 1994 ; 91 : 8731–8. [CrossRef] [PubMed] [Google Scholar]
  2. Luft R, Ikkos D, Palmieri G, et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962 ; 41 : 1776–804. [CrossRef] [PubMed] [Google Scholar]
  3. DiMauro S, Garone C. Historical perspective on mitochondrial medicine. Dev Disabil Res Rev 2010 ; 16 : 106–13. [CrossRef] [PubMed] [Google Scholar]
  4. DiMauro S, Bonilla E, Zeviani M, et al. Mitochondrial myopathies. Ann Neurol 1985 ; 17 : 521–38. [CrossRef] [PubMed] [Google Scholar]
  5. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981 ; 290 : 457–65. [CrossRef] [PubMed] [Google Scholar]
  6. Holt IJ, Harding AE, Morgan-Hugues JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988 : 331 : 717–9. [CrossRef] [PubMed] [Google Scholar]
  7. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988 ; 242 : 1427–30. [CrossRef] [PubMed] [Google Scholar]
  8. DiMauro S. Mitochondrial medicine. Biochim Biophys Acta Bioenerg 2004 ; 1659 : 107–14. [CrossRef] [Google Scholar]
  9. Bourgeron T, Rustin P, Chrétien D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995 ; 11 : 144–9. [CrossRef] [PubMed] [Google Scholar]
  10. Rouzier C, Pion E, Chaussenot A, et al. Primary mitochondrial disorders and mimics: Insights from a large French cohort. Ann Clin Transl Neurol 2024 ; 11 :1478–91. [CrossRef] [PubMed] [Google Scholar]
  11. Evangelista T. Le réseau européen de référence pour les maladies neuromusculaires rares (EURO-NMD) : de sa constitution à ses premiers pas. Med Sci (Paris) 2019 ; 35 : 51–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Dollfus H. Le plan France Médecine Génomique 2025 et les maladies rares. Med Sci (Paris) 2018 ; 34 : 39–41. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Wallace DC, Lott MT, Procaccio V. Mitochondrial biology and medicine. In : Emery and Rimoin’s principles and practice of medical genetics and genomics. New York : Academic Press, 2019. pp. 267–322. [CrossRef] [Google Scholar]
  14. Ruiz-Pesini E, Mishmar D, Brandon M, et al. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 2004 ; 303 : 223–6. [CrossRef] [PubMed] [Google Scholar]
  15. Guchet X. La médecine personnalisée : un essai philosophique. Paris : Les Belles Lettres, 2016. [Google Scholar]
  16. Lévêque M, Marlin S, Jonard L, et al. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. Eur J Hum Genet 2007 ; 15 : 1145–55. [CrossRef] [PubMed] [Google Scholar]
  17. Bannwarth S, Procaccio V, Paquis-Flucklinger V. Surveyor™ nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. Hum Mutat 2005 ; 25 : 575–82. [CrossRef] [PubMed] [Google Scholar]
  18. Bannwarth S, Procaccio V, Lebre AS, et al. Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders. J Med Genet 2013 ; 50 : 704–14. [CrossRef] [PubMed] [Google Scholar]
  19. Rahman J, Rahman S. Mitochondrial medicine in the omics era. Lancet 2018 ; 391 : 2560–74. [CrossRef] [PubMed] [Google Scholar]
  20. Gorokhova S, Rouzier C, Acquaviva-Bourdain C, et al. Interprétation des résultats issus du séquençage à haut débit pour les maladies génétiques : mise en place d’une homogénéisation nationale en France. Med Sci (Paris) 2024 ; 40 : 767–9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  21. Protocole national de diagnostic et de soins pour les « Maladies mitochondriales apparentées au MELAS » : https://www.has-sante.fr/upload/docs/application/pdf/2021-09/pnds_melas_argumentaire_septembre_2021.pdf [Google Scholar]
  22. Berardo A, Domínguez-González C, Engelstad K, et al. Advances in thymidine kinase 2 deficiency: clinical aspects, translational progress, and emerging therapies. J Neuromuscul Dis 2022 ; 9 : 225–35. [CrossRef] [PubMed] [Google Scholar]
  23. Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov 2018 ; 17 : 865–86. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.